Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 21, 2025 • 10:31 PM ET

Date/Time Source News Release
01/07/2025 08:00 AM EST GlobeNewswire Grace Therapeutics to Participate in Upcoming Investor Events January 2025
12/04/2024 08:00 AM EST GlobeNewswire Grace Therapeutics to Exhibit at the American Society of Health-System Pharmacists Conference
10/25/2024 08:00 AM EDT GlobeNewswire Acasti Announces Corporate Name Change to Grace Therapeutics, Inc.
09/25/2024 07:30 AM EDT GlobeNewswire Acasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104
09/20/2024 08:35 AM EDT GlobeNewswire Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
09/16/2024 12:07 PM EDT GlobeNewswire Life Sciences Virtual Investor Forum Agenda Announced for September 19th
09/12/2024 08:00 AM EDT GlobeNewswire Acasti to Present at the Life Sciences Investor Forum
09/05/2024 10:35 AM EDT GlobeNewswire Acasti to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
08/09/2024 08:00 AM EDT GlobeNewswire Acasti Announces First Fiscal Quarter 2025 Financial Results, Provides Business Update
06/27/2024 04:05 PM EDT GlobeNewswire Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial
Page

Additional News

As of January 21, 2025 • 10:31 PM ET

Date/Time Source News Release
Page